Patents by Inventor Jean-Jacques Morgenthaler

Jean-Jacques Morgenthaler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6407212
    Abstract: For separating non-conventional transmissible agents (NCTAs), i.e. causative agent(s), of transmissible spongiform encephalopathies (TSEs) from a solution of a protein susceptible to contamination with NCTAs, particularly from blood products, at least one adsorbent is suspended, for a time of at least 10 minutes. The absorbent is selected from kieselguhr, diatomaceous earth, silicic acid, clay minerals, metal hydroxide, metal oxihydrate, cellulose, perlite, bentonite, and water-insoluble synthetic polymers. The obtained suspension is agitated, and subsequently the adsorbent is separated from the protein solution.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: June 18, 2002
    Assignee: ZLB Bioplasma AG
    Inventors: Jean-Jacques Morgenthaler, Jacques-Andre Maring, Markus Rentsch
  • Patent number: 5912328
    Abstract: In order to separate viruses from protein solutions, particles of a solid phase are suspended in said protein solution. The solid phase is an adsorbent chosen from the group kieselguhr, silicic acid, clay minerals, metal hydroxide or oxihydrate, cellulose, perlite, and water insoluble synthetic polymers. Subsequently the solid phase together with the viruses that have adsorbed to it is separated from the fluid phase. The protein solution is brought into contact at least once with the solid phase for at least 10 minutes during which time a suspension is formed; subsequently the solid phase is separated from the liquid phase.
    Type: Grant
    Filed: October 7, 1997
    Date of Patent: June 15, 1999
    Assignee: Rotkreuzstiftung Zentrallaboratorium Blutspendedienst
    Inventors: Adames Omar, Jean-Jacques Morgenthaler
  • Patent number: 5696236
    Abstract: In order to separate viruses from protein solutions, particles of a solid phase are suspended in said protein solution. The solid phase is an adsorbent chosen from the group kieselguhr, silicic acid, clay minerals, metal hydroxide or oxihydrate, cellulose, perlite, and water insoluble synthetic polymers. Subsequently the solid phase together with the viruses that have adsorbed to it is separated from the fluid phase. The protein solution is brought into contact at least once with the solid phase for at least 10 minutes during which time a suspension is formed; subsequently the solid phase is separated from the liquid phase.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: December 9, 1997
    Assignee: Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SKR
    Inventors: Adames Omar, Jean-Jacques Morgenthaler